Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Lemborexant patent expiration?Amoxicillin production cost?Lemborexant generic availability 2026?Levemir expiration date?Cequa eye drops cost?
See the DrugPatentWatch profile for Micafungin
Micafungin belongs to the echinocandin class of antifungal medications. Echinocandins work by inhibiting fungal cell wall synthesis.
As an echinocandin, micafungin targets beta-(1,3)-D-glucan synthesis, which is a key component of many fungal cell walls. Disrupting that process weakens the fungal cell wall and leads to antifungal activity.
In clinical practice, micafungin is used for serious fungal infections where an echinocandin is appropriate, particularly candidiasis (yeast infections).
Micafungin is different from: - Azoles (like fluconazole): inhibit fungal ergosterol synthesis. - Polenes (like amphotericin B): bind fungal cell membrane components. - Allylamines (like terbinafine): inhibit a different fungal sterol pathway. Because micafungin is an echinocandin, its cell-wall mechanism distinguishes it from those other classes.
No. Micafungin is an antifungal (infectious-disease) medication, not a chemotherapy drug.
Other Questions About Micafungin :